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Introduction 
The 2010 Drug Strategy1 makes a commitment to support communities to “build 
networks of ‘Recovery Champions’ who will spread the message that recovery is 
worth aspiring to and help those starting their journey.” It envisages the creation of 
‘Recovery Champions’ in local areas, and this includes ‘strategic recovery 
champions’ – people in strategic positions, such as Directors of Public Health 
(DPH) and substance misuse commissioners, to promote systems which are both 
evidence based and ‘recovery oriented’. 
This briefing is part of a programme of work conducted by DrugScope on behalf of 
the Recovery Partnership, which considers the challenges and opportunities 
associated with advocating for treatment and recovery at the strategic level, seeks 
to share good practice and offers support to those occupying strategic positions in 
the drug and alcohol sector.  
It brings together the findings from the initial part of the project, which include 
telephone discussions with commissioners and a roundtable event held in March 
2015, attended by drug and alcohol commissioners from around England. In 
addition to acknowledging the challenges that substance misuse commissioners 
face, it also includes some suggestions of how commissioners might make the 
case for substance misuse treatment at a time of budgetary constraints and 
competing public health and social priorities.  
It considers the challenges that drug and alcohol commissioners face in making 
the case for engagement with and investment in the sector, challenges which may 
include budgetary constraints at a time of austerity, the existence of competing 
priorities in public health, and the difficulties associated with building and 
sustaining effective partnerships. However, roundtable participants shared many 
examples of good practice in attempts to overcome these challenges, and these 
represent the focus of this paper. Case studies, developed with commissioners 
from Lancashire and Sutton, offer two examples of how this has been achieved in 
practice. The paper concludes with recommendations for drug and alcohol 
1 Home Office (2010) Drug Strategy 2010: Reducing demand, restricting supply, building recovery. Accessed online at 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/118336/drug-strategy-2010.pdf  
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commissioners looking to make the case for the sector at the strategic level, and 
signposting to resources which may be useful to this end.  
Context 
There was a recognition among the participants at the roundtable that the drug 
and alcohol commissioning landscape is changing. Not only has there been 
greater integration of drug services with alcohol services, but the Review of drug 
and alcohol commissioning2 conducted by Public Health England (PHE) and the 
Association of Directors of Public Health (ADPH) indicates that many local areas 
are exploring greater integration of substance misuse services with related fields, 
such as housing, criminal justice, and mental health. This shift brings with it 
opportunities for commissioners – to build new partnerships in ways which 
address local need, for instance, and to offer better joined-up support for people 
with multiple and complex needs.  
Building partnerships 
However, the current commissioning environment also presents a number of 
challenges for those advocating for treatment and recovery in strategic roles. 
While the nature and degree of partnership work was characterised by 
considerable variation, many roundtable participants reported that building 
effective partnerships can be extremely challenging. In a context of budgetary 
constraints across the public sector, limited resources and competing priorities, it 
was put forward that potential partners do not always have the capacity to engage 
on a meaningful level with the substance misuse agenda. In addition, where 
investment in drug and alcohol services has been deprioritised at a local level, it 
was suggested that potential partners may be less likely to engage proactively with 
the sector, particularly given the risk of retrenchment at a time of financial 
challenge for public services.  
Some commissioners present reported that GPs and pharmacies can be difficult to 
engage with, they have their own duties to fulfil and targets to meet, and 
substance misuse is not their primary concern. Others noted that Community 
Rehabilitation Companies (CRCs) and Police and Crime Commissioners (PCCs) 
2 Public Health England and the Association of Directors of Public Health. Review of Public Health Commissioning. Ac-
cessed online at http://www.nta.nhs.uk/uploads/review-of-drug-and-alcohol-commissioning-2014.pdf 
Advocating for Treatment and Recovery at the Strategic Level 
4 
consider substance misuse beyond their remit, and some expressed the concern 
that Clinical Commissioning Groups (CCGs) are not active participants or well 
engaged with the substance misuse agenda. However, other participants said that 
GPs, CCGs, and PCCs had been important sources of support for the substance 
misuse agenda in their own local areas, even providing funding for specific 
projects that meet these partners’ agendas. One example cited was the provision 
of funding from a CCG to a substance misuse team, to work towards reducing 
alcohol related hospital admissions.   
Budgetary constraints and reduction in capacity 
Respondents to the survey of commissioners conducted by PHE and ADPH 
reported that maintaining sustainable drug and alcohol services in the face of 
uncertainty surrounding future funding, including the potential impact of removing 
the ring-fence on the public health grant, represents a significant challenge.3 
DrugScope’s State of the Sector 2014-15 survey suggests that these concerns are 
shared by many service providers. 60 community services and 11 residential 
services reported a decrease in funding over the previous year, compared to only 
17 and 11 reporting an increase respectively.4  
According to the State of the Sector 2014-2015 survey, 53% of respondents 
reported a reduction in front line staff, and 40% reported a reduction in back office 
staff and managers. Several participants at the roundtable reported that the drug 
and alcohol teams in their areas had also experienced significant capacity 
reductions, with one commissioner reporting that with the transition to public 
health in April 2013, their Drug and Alcohol Action Team (DAAT) decreased from 
20 people to 2.5 people. Similar concerns surrounding the capacity of 
commissioning teams were also identified as a key challenge for commissioners in 
the PHE/ADPH survey. More recent research found that Directors of Public Health 
(DsPH) have also expressed concerns about the potential removal of the ring-
fence on the public health grant, and are experiencing difficulties in making the 
case for investment in public health more broadly.5 
3 Public Health England and the Association of Directors of Public Health. Review of Public Health Commissioning. Ac-
cessed online at http://www.nta.nhs.uk/uploads/review-of-drug-and-alcohol-commissioning-2014.pdf  
4 DrugScope (2015) State of the Sector 2014-15. Accessed online at http://www.drugscope.org.uk/Resources/
Drugscope/Documents/PDF/Policy/SoSFinal2015.pdf  
5 Willmott, M., Womack, J., Hollingworth, W. and Campbell, R. (2015) Making the case for investment in public health: 
experiences of Directors of public Health in English local government. Journal of Public Health. Accessed online at http://
jpubhealth.oxfordjournals.org/content/early/2015/03/15/pubmed.fdv035.short?rss=1  
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Competing priorities 
Another key challenge communicated by many of the commissioners at the 
roundtable was making the case for substance misuse treatment and recovery 
within a context of multiple agendas in public health and related areas, such as 
obesity, smoking cessation, children and families, and community safety. While 
reducing harmful drinking and smoking cessation are listed among PHE’s seven 
priorities for the next five years6, drug misuse and treatment does not feature in 
this list. 
 The inclusion of the new condition attached to the ring fenced public health grant 
for 2015-16, which states that local authorities should seek to improve the take 
up of and outcomes from drug and alcohol treatment services7, is welcome. So too 
is the inclusion of the drug treatment indicator as part of the Health Premium 
Incentive Scheme, to reward local authorities for health improvements in this 
area8, though the efficacy of both of these are untested Commissioners need to 
consider the many ways in which addressing drug and alcohol problems 
contributes to other public health priorities and outcomes. Developing creative 
approaches of this kind has the potential to deliver outcomes across the public 
health agenda while also reducing expenditure. 
Many participants at the roundtable recognised valuable and innovative 
approaches to treatment and recovery that emerged in their local areas outside of 
traditional commissioning structures. For instance, commissioners referred to peer
-led recovery groups which they felt were making an important contribution 
towards helping people to develop sustained recovery and engage with the wider 
community. While some commissioners reported that they have been able to 
support these projects, it was also noted that supporting non-traditional initiatives 
such as peer-led projects can involve taking calculated risks. 
6 Public Health England (2014) From evidence into action: opportunities to protect and improve the nation’s health. 
Accessed online at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/366852/
PHE_Priorities.pdf  
7 Department of Health (2014) Local Authority Circular 17th December 2014. Accessed online at https://www.gov.uk/
government/uploads/system/uploads/attachment_data/
file/388172final_PH_grant_determination_and_conditions_2015_16.pdf  
8. Department of Health and Public Health England (2015) Health Premium Incentive Scheme. Response to Technical 
Consultation. Accessed online at https://www.gov.uk/government/uploads/system/uploads/attachment_data/
file/410815/health-premium-respons.pdf  
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Encouragingly, participants at the roundtable shared many examples of ways in 
which they have worked strategically to address these issues, and in doing so 
continue to make the case for drug and alcohol treatment and recovery effectively 
within a challenging context.  
Making recovery visible 
With less political focus on substance misuse, commissioners highlighted the 
importance of making recovery visible to others in strategic positions, including 
Directors of Public Health and Police and Crime Commissioners, in order to 
Case Study: Engaging strategic recovery champions in 
Lancashire 
Over recent years, commissioning in Lancashire has seen the growth of recovery 
orientated treatment provision, the development and growth of an independent and 
visible recovery community and the development of a new recovery infrastructure 
organisation. This approach has been driven by a strategic view that recovery can-
not be commissioned, but those occupying strategic positions can commission the 
space for recovery to develop and grow into an independent, sustainable and di-
verse community; recovery is not something treatment services do to people, it is 
what people do for themselves. 
The visible recovery community is built in part on the success of the Lancashire 
User Forum (LUF). The LUF is one of the biggest recovery forums in the country, 
meeting both on a locality basis (North, East and Central Lancashire) but also on a 
county basis, and this has developed into a mini conference every two months. 
Emerging out of the LUF and the Recovery Infrastructure Organisation (RIO), deliv-
ered by Red Rose Recovery, are a number of volunteer activities such as 'flash' 
community clean ups. Commissioners have also created a 'building recovery in 
communities' (BRIC) fund which is managed by the recovery community itself, and 
has been used to fund events, new groups including family forums, social enter-
prises, and sporting activities. 
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generate support for and investment in the work of the sector. It was emphasised 
that data on treatment penetration and outcomes is an indispensable means 
through which to demonstrate the value of the drug and alcohol system, but that it 
is also important to expose others in strategic positions to the value of recovery 
more broadly. While this may be more difficult to quantify, it was suggested that 
physically showing these individuals the work that drug and alcohol services and 
recovery communities do can be an effective means through which to get them on 
board with the treatment and recovery agenda.  
Despite the frustrations that some commissioners had experienced in their 
attempts to sustain existing strategic partnerships and build new ones, several 
roundtable participants emphasised the value of continued efforts in this area.  
Supporting other agendas 
A widely expressed view at the roundtable was that a crucial aspect of making the 
strategic case for drug and alcohol treatment and recovery is to show that 
addressing substance misuse helps to deliver on other agendas which are 
The reality of asset-based commissioning has proved attractive and has been cru-
cial in enabling the development of strategic recovery champions. The Director for 
Public Health in Lancashire gave up a day of his schedule in 2014 to do a 'deep 
dive' into treatment and recovery, to witness first-hand the reality of recovery ori-
ented treatment, the role of peer mentors and the achievements of the broader re-
covery community, including social enterprises.  
Attention from other national figures has included the PHE Recovery Lead, Chief 
Executive of PHE Duncan Selbie, Members of Parliament, the Minister for Public 
Health, the head of Civil Service and Lancashire County Council’s Chief Executive, 
and this attention has significantly increased ‘buy in’ at the strategic level.  
This positive attention has been beneficial for all involved, particularly the recovery 
community itself which has had its identity and achievements affirmed.  
For further information, please contact jameschris.lee@lancashire.gov.uk 
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Case Study: The Accident and Emergency (A & E) pilot at 
St Helier Hospital, Sutton: A change to the norm.  
Sutton drug and alcohol commissioners have developed a pilot which aims to give 
drug and alcohol workers access to patients in A & E departments, ensure all 
patients entering A & E with drug and alcohol related needs are seen by a 
professional, and reduce drug and alcohol related re-entry to A & E. The key 
criteria for this pilot was that all key stakeholders would be on board and would 
be passionate about its success.  
Initially commissioners met with the Urgent Care Board to ascertain the level of 
buy in, and met a motivated team of staff, from the ambulance team to the head 
of urgent care. Commissioners met with A & E staff regularly and, due to the 
interest in the plan from the first consultant for A & E, more consultants as well as 
frontline staff and administrative staff joined the meetings to give their views. The 
commissioners were clear that they wanted all members of the A & E team on 
board as they all play a crucial role in the patient pathway. The administration 
manager and her team provided important support in the production of statistics 
that could be measured against the next year, and the final Project Initiation 
Document (PID) was produced.  
Setting this up was more complex than just attending meetings and writing a PID. 
Ensuring that everyone remained motivated and saw the worth of the project 
involved several steps: 
 Arranging intervention and brief advice training for all local providers 
 Negotiating funding for emergency sickness cover for A & E 
 Regularly meeting with all of the team at their chosen venue  
 Agreeing alterations up to the date of commencement and convening 
regular meetings to ensure change was continuous 
 Paying consultants to attend meetings so they can cover their absence 
 Organising further training to include novel psychoactive substances (NPS), 
chemsex, men who have sex with men (MSM), blood borne viruses (BBV), 
HIV, hepatitis C, and harm reduction so that all staff have a chance to 
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engage in effective training which was Continuing Professional Development 
(CPD) certified 
 Extending the pilot to include a ward liaison post, so that those clients who 
are admitted to the wards from A & E receive the same service as those in A & 
E. 
The project is still subject to evaluation. Whether or not it generates a decrease in 
the amount of re-entry to A & E, the pilot will at least ensure that everyone who 
enters A & E with drug or alcohol related needs will be seen by a professional at the 
most likely time for them to engage – no one will enter A & E and not be followed 
up, and no one will be admitted to the wards at St. Helier and not seen by a senior 
clinician, assessed, followed through and kept engaged within services.  
In the experience of the commissioner leading the pilot, the most relevant points 
for any commissioner or service engaging with external stakeholders are: 
 Work closely with external stakeholders on projects which will affect them is 
essential 
 Be proactive: go to meetings and talk to the people you need to engage (some 
people will get on board because of their belief in you as an individual, as 
much as their belief in the role) 
 Always consider advice provided and re-write documents as many times as 
needed to get them right 
 Work with the service professionals 
 Keep working with the team to ensure the idea continues to develop 
 Work the occasional weekend to help engage with the work of the team 
 Show appreciation towards the other key stakeholders for their work on your 
project. 
For further information, please contact rebecca.hayden@sutton.gov.uk 
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considered to be local or national priorities. It was suggested that this is 
particularly important in attempts to build or sustain partnerships at a time when 
most potential partners are working with limited resources.  
Commissioners suggested that in order to do this, they had attended meetings 
held by potential partners, some of which were not directly relevant to their own 
work (GPs meetings, for instance). These meetings could function as a platform 
from which to advocate for treatment and recovery, and to convince potential 
partners that engaging with the substance misuse agenda could help them to 
meet their own agendas. 
Making the ‘value for money’ case 
Participants at the roundtable emphasised the need to demonstrate the value for 
money of drug and alcohol interventions when making the case for treatment and 
recovery. PHE suggest that focusing on social return on investment (SROI) can 
help local authorities to make informed decisions about public spending, and that 
it is crucial the substance misuse sector shows local decision makers where 
investment in the sector contributes to public health, social care, and community 
safety outcomes.9 In order to conduct an SROI analysis, the relationship between 
the inputs (for instance financial investment or paid/volunteer work), outputs 
(including the number of people receiving and completing treatment), and 
outcomes (for example improved health and reduction in criminal activity) of drug 
and alcohol interventions must be illustrated. The outcomes must also be 
evidenced and given a value so that the SROI may be calculated.10  
It was also highlighted that the drug and alcohol sector has been extremely 
successful in the past in demonstrating value for money, particularly with regard to 
HIV/AIDS and reducing rates of acquisitive crime. Some commissioners 
emphasised that these kind of cost-benefit arguments can be given new focus and 
force where information and communication resources spell out the health, social, 
and economic costs of disinvestment. Commissioners wishing to present the 
bigger picture on treatment and recovery and caution against the risks of 
9 Public Health England (2015) A guide to social return on investment for alcohol and drug treatment commissioners. 
Accessed online at http://www.nta.nhs.uk/publications.aspx  
10 More information on calculating SROI can be found in the PHE guide, which can be accessed at this link: http://
www.nta.nhs.uk/uploads/a-guide-to-social-return-on-investment-for-alcohol-and-drug-treatment-commissioners.pdf 
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disinvestment may find DrugScope’s Making the Case guide11 and PHE’s Local 
Value for Money and Cost Effectiveness tools12 useful. 
Conclusions and Recommendations 
Drug and alcohol commissioners face a number of challenges in their attempts to 
maintain and increase investment in and engagement with the sector, including 
budgetary constraints, competing public health priorities, and difficulties around 
building effective partnerships. While the scale of this challenge should not be 
underestimated, encouragingly participants at the roundtable were able to share 
many examples of good practice and suggest ways in which these challenges 
might be addressed.  
Key recommendations for commissioners looking to advocate for drug and alcohol 
treatment and recovery that emerged from the roundtable include: 
 Make the impact of treatment and recovery visible by showing others in 
strategic roles promising services and initiatives. This might include 
councillors, the DPH, PHE representatives or individuals from related sectors, 
for instance PCCs.  
 Demonstrate that drug and alcohol interventions can support other agendas 
and function as vehicles for the delivery of broader health and social 
outcomes – which might include reductions in criminal activity or alcohol 
related hospital admissions.  
 Map out the variety of ways in which drug and alcohol services can deliver to 
public health, social inclusion, and criminal justice outcomes. 
 In order to build partnerships, attend the meetings of potential partners 
(GPs, for instance) and utilise these meetings as a platform from which to 
make the case for the drug and alcohol sector. 
 In order to sustain projects with external partners, work collaboratively with 
the relevant partners so they have a say in work that will affect them. 
 11 DrugScope (2014) Making the Case: A practical guide to promoting drug and alcohol treatment and recovery ser-
vices locally. Accessed online at http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Policy/
MakingTheCase.pdf  
12 Public Health England (2014)  The Local Value for Money and Cost-Effectiveness Tools: Demonstrating the return on 
investment of drug treatment. Accessed online at http://www.lho.org.uk/Download/Public/18361/1/140129%20London%
20K&I%20network%20-%20Virginia% 
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 Demonstrate the value for money that drug and alcohol treatment 
represents, potentially focusing on SROI, and consider mapping out the 
health, social, and economic consequences of disinvestment in substance 
misuse., as well as using the available cost benefit analysis and information 
and communications resources 
 
 
Resources: 
Alcohol Concern, Centre for Mental Health, and DrugScope Making recovery a 
reality in your community - A briefing for commissioners of mental health, drug and 
alcohol services. http://www.centreformentalhealth.org.uk/pdfs/
recovery_dual_diagnosis_paper_2013.pdf 
DrugScope’s Making the Case - A practical guide to promoting treatment and 
recovery http://www.drugscope.org.uk/POLICY+TOPICS/
Making+the+case+for+drug+and+alcohol+services 
PHE tools to help local areas develop JSNAs and joint health and wellbeing 
strategies and to communicate the benefit of investing in drugs and alcohol 
treatment locally http://www.nta.nhs.uk/healthcare-JSNA.aspx 
PHE Guide to social return on investment for alcohol and drug commissioners 
http://www.nta.nhs.uk/uploads/a-guide-to-social-return-on-investment-for-alcohol-
and-drug-treatment-commissioners.pdf  
PHE The Local Value for Money and Cost-Effectiveness Tools: Demonstrating the 
return on investment of drug treatment. http://www.lho.org.uk/Download/
Public/18361/1/140129%20London%20K&I%20network%20-%20Virginia%
20Musto%20-%20PHE%20drugs%20treatment%20value%20for%20money%
20tool.pdf 
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Appendix 
The roundtable on advocating for recovery and treatment at a strategic level took 
place on Tuesday 10th March 2015 at The Guildhall, London, 2pm – 4.30pm. 
DrugScope would like to thank the Guildhall and the London Drug and Alcohol 
Policy Network for hosting the event, and the participants of the roundtable for 
their valuable contribution to this briefing. 
Attendees 
Andrew Brown, DrugScope (Presentation) 
Julanta Carriere, Waltham Forest 
Anne Charlesworth, Rotherham 
Andy Collins, Doncaster 
Lauren Garland, DrugScope 
Nick Germain, Doncaster 
Rebecca Hayden, Sutton (Local overview) 
Elaine Hopwood, Dudley  
Paul Jessop, DrugScope 
Will Johnston, Warwickshire 
Chris Lee, Lancashire (Presentation) 
David MackIntosh, London Drug and Alcohol Policy Network (Chair) 
Steve O’Neill, Gloucestershire (Local overview) 
Michael Pierce, Merton (Local overview) 
Katherine Reid, West London Tri-Borough 
Dr Marcus Roberts, DrugScope 
Kathryn Scott, Hackney 
Carole Sharma, Federation of Drug and Alcohol Professionals 
Bhavna Taank, Telford and Wrekin 
Rosie Winyard, Worcestershire    
James Yallop, Sutton 
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About DrugScope and the Recovery Partnership 
DrugScope is the national membership organisation for the drug and alcohol field and is 
the UK’s leading independent centre of expertise on drugs and drug use. We represent 
more than 300 member organisations involved in drug and alcohol treatment, 
supporting recovery, young people’s services, drug education, prison and offender 
services, as well as related services such as mental health and homelessness. 
DrugScope is a registered charity (number 255030). Further information is available at: 
http://www.drugscope.org.uk/  
DrugScope, the Recovery Group UK and the Substance Misuse Skills Consortium 
formed the Recovery Partnership in May 2011 to provide a new collective voice and 
channel for communication to ministers and officials on the achievement of the 
ambitions set out in the 2010 Drug Strategy. The Recovery Partnership is able to draw 
on the expertise of a broad range of organisations, interest groups as well as service 
user groups and voices. More information is available at: http://www.drugscope.org.uk/
partnersandprojects/Recovery+Partnership 
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